Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Orthopedic, Surgical Sales Help Offset 12% Cordis Decline In 2008

This article was originally published in The Gray Sheet

Executive Summary

Sales in Johnson & Johnson's devices and diagnostics business in the fourth quarter were down in the U.S. and close to flat worldwide, with revenue from its DePuy orthopedic and Ethicon Endo-Surgery units offsetting a dismal performance from the Cordis franchise
Advertisement

Related Content

J&J Nevo Stent Inhibits Tissue Proliferation Better Than Boston Sci’s Liberté
J&J Nevo Stent Inhibits Tissue Proliferation Better Than Boston Sci’s Liberté
J&J Nevo goes head-to-head with Abbott Xience V
J&J Nevo goes head-to-head with Abbott Xience V
J&J Adds Aesthetics To Ethicon With $1.07 Billion Mentor Acquisition
Abbott’s Xience Stent Launch Drives Sales, Stock Gains In Third Quarter
Abbott’s Xience Stent Launch Drives Sales, Stock Gains In Third Quarter
Cordis Pipeline Includes Stents, A-Fib Ablation, Percutaneous AAA Repair

Topics

Advertisement
UsernamePublicRestriction

Register

MT027036

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel